GMED Stock: Globus Medical, Inc. Stock Price, Analysis & Insights
Get live GMED stock price $80.86, comprehensive Globus Medical, Inc. stock analysis, charts, news, and expert forecast. Real-time GMED stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extens...
Company Information
- CEO
- Keith W. Pfeil
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 5300
Contact Information
- Address
- 2560 General Armistead Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 17.9)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Globus Medical, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Globus Medical, Inc.
- ⚠Investors should consider how Globus Medical, Inc. fits within their overall portfolio allocation
Market Cap
10.91B
P/E Ratio (TTM)
17.93
Beta
0.95
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare GMED with peer companies:
- Price
- $170.50
- Market cap
- 12.21B
- Price
- $114.67
- Market cap
- 7.32B
- Price
- $291.01
- Market cap
- 7.87B
- Price
- $198.54
- Market cap
- 12.75B
- Price
- $7.32
- Market cap
- 6.19B
- Price
- $89.72
- Market cap
- 7.50B
- Price
- $78.85
- Market cap
- 8.98B
- Price
- $197.89
- Market cap
- 10.31B
- Price
- $319.34
- Market cap
- 12.56B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.